14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $60.37 $79.59 Tuesday, 23rd Apr 2024 EXAS stock ended at $63.53. This is 1.79% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 4.14% from a day low at $62.42 to a day high of $65.00.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Nov 28, 2023 $65.26 $65.49 $63.57 $64.97 877 163
Nov 27, 2023 $65.47 $66.71 $64.03 $65.82 959 608
Nov 24, 2023 $65.90 $66.44 $65.20 $65.99 321 433
Nov 22, 2023 $65.83 $66.80 $64.84 $65.38 578 986
Nov 21, 2023 $67.13 $67.70 $65.13 $65.14 1 073 076
Nov 20, 2023 $66.42 $69.26 $66.31 $67.29 1 841 225
Nov 17, 2023 $61.90 $66.46 $60.99 $66.30 2 044 736
Nov 16, 2023 $63.03 $63.43 $60.70 $61.17 1 151 395
Nov 15, 2023 $63.27 $64.79 $62.91 $63.12 1 482 162
Nov 14, 2023 $62.41 $63.97 $62.17 $63.46 1 961 766
Nov 13, 2023 $59.31 $60.34 $58.43 $59.27 2 025 450
Nov 10, 2023 $59.50 $60.37 $58.52 $59.76 1 523 736
Nov 09, 2023 $63.11 $63.40 $59.53 $59.64 1 504 822
Nov 08, 2023 $64.71 $64.83 $62.17 $62.84 1 579 879
Nov 07, 2023 $65.60 $66.39 $64.44 $65.30 1 186 536
Nov 06, 2023 $67.27 $67.83 $65.18 $65.20 1 614 350
Nov 03, 2023 $63.27 $68.02 $63.22 $67.02 2 293 986
Nov 02, 2023 $63.15 $66.49 $61.54 $62.46 2 459 482
Nov 01, 2023 $61.20 $63.76 $60.71 $63.52 2 422 356
Oct 31, 2023 $59.24 $61.75 $59.00 $61.59 1 389 540
Oct 30, 2023 $60.29 $60.70 $58.53 $59.06 1 857 058
Oct 27, 2023 $62.02 $62.02 $59.44 $59.72 1 448 416
Oct 26, 2023 $61.52 $62.71 $61.17 $61.38 1 435 456
Oct 25, 2023 $64.95 $65.49 $61.39 $61.81 1 304 264
Oct 24, 2023 $64.59 $65.84 $64.25 $65.76 1 069 852
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT